Nasal delivery of Fasudil-modified immune cells exhibits therapeutic potential in experimental autoimmune encephalomyelitis.

Shang-De GuoChun-Yun LiuJing-Wen YuZhi ChaiQing WangXi-Ting MiGuo-Bin SongYan-Hua LiPeng-Wei YangLing FengBao-Guo XiaoCun-Gen Ma

Published in: CNS neuroscience & therapeutics (2019)

Our results indicate that intranasal delivery of Fasudil-modified MNCs have therapeutic potential in EAE, providing a safe and effective cell therapeutic strategy to MS and/or other related disorders.

Keyphrases

mass spectrometry
single cell
multiple sclerosis
ms ms
cell therapy
stem cells
mesenchymal stem cells